A Dark Vector Cognition product

MetLife 10-Q 2026-09-30

MET · CIK 1099219 · Form 10-Q · Period ended September 30, 2026 · Filed November 6, 2026

Revenue rose 18.2% to $20.5 billion. Operating margin was 8.9%, against 9.5% a year earlier. Net income was $2.40 billion.

8 sections, 810K characters. Original on sec.gov · ·

Risk FactorsBusiness

Key numbers
MeasureQuarter ended Sep 30, 2026Quarter ended Sep 30, 2025Change
Revenue$20.5B$17.4B+18.2%
Operating income$1.83B$1.65B+10.7%
Net income$2.40B$896M+168%
Diluted EPS$3.67$1.22+201%
Cash and equivalents$19.8Bn/an/a
Operating margin*8.9%9.5%-0.6 pts

From the XBRL facts tagged to this filing; both columns are as reported in this filing. * Computed by filings.tools: free cash flow is operating cash flow less capital spending; operating margin is operating income over revenue.

The 165 tables in this filing as one CSV, figures in aligned columns. For subscribers: paste your API key. One API call. Plans from $19 a month, see pricing.

Cover and table of contents

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

☑QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2026

or

☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE TRANSITION PERIOD FROM TO

Commission file number: 001-15787

_____________________________________

MetLife, Inc.

(Exact name of registrant as specified in its charter)

Delaware13-4075851
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)
200 Park Avenue,New York,NY10166-0188
(Address of principal executive offices)(Zip Code)

(212) 578-9500

**(**Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01METNew York Stock Exchange
Floating Rate Non-Cumulative Preferred Stock, Series A, par value $0.01MET PRANew York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of 5.625% Non-Cumulative Preferred Stock, Series EMET PRENew York Stock Exchange
Depositary Shares, each representing a 1/1,000th interest in a share of 4.75% Non-Cumulative Preferred Stock, Series FMET PRFNew York Stock Exchange

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer☑Accelerated filer☐
Non-accelerated filer☐Smaller reporting company☐
Emerging growth company☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

At October 30, 2026, 628,442,143 shares of the registrant’s common stock were outstanding.

Table of Contents

Page
Part I — Financial Information
Item 1.Financial Statements (Unaudited) (at September 30, 2026 and December 31, 2025 and for the Three Months and Nine Months Ended September 30, 2026 and 2025)
Interim Condensed Consolidated Balance Sheets4
Interim Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)5
Interim Condensed Consolidated Statements of Equity6
Interim Condensed Consolidated Statements of Cash Flows7
Notes to the Interim Condensed Consolidated Financial Statements:
Note 1 — Business, Basis of Presentation and Summary of Significant Accounting Policies8
Note 2 — Segment Information9
Note 3 — Acquisitions and Dispositions15
Note 4 — Future Policy Benefits16
Note 5 — Policyholder Account Balances26
Note 6 — Market Risk Benefits35
Note 7 — Separate Accounts38
Note 8 — Deferred Policy Acquisition Costs, Value of Business Acquired and Unearned Revenue42
Note 9 — Investments44
Note 10 — Derivatives61
Note 11 — Fair Value72
Note 12 — Subordinated Debt Securities87
Note 13 — Equity88
Note 14 — Other Revenues and Other Expenses93
Note 15 — Employee Benefit Plans94
Note 16 — Income Tax95
Note 17 — Earnings Per Common Share95
Note 18 — Contingencies, Commitments and Guarantees96
Note 19 — Related Party Transactions99
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations100
Item 3.Quantitative and Qualitative Disclosures About Market Risk152
Item 4.Controls and Procedures153
Part II — Other Information
Item 1.Legal Proceedings154
Item 1A.Risk Factors154
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds154
Item 5.Other Information155
Item 6.Exhibits156
Glossary157
Signatures160

Table of Contents

As used in this Form 10‑Q, “MetLife,” the “Company,” “we,” “our” and “us” refer to MetLife, Inc., a Delaware corporation incorporated in 1999, its subsidiaries and affiliates.

Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10‑Q, including Management’s Discussion and Analysis of Financial Condition and Results of Operations, may contain or incorporate by reference information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give expectations or forecasts of future events and do not relate strictly to historical or current facts. They use words and terms such as “anticipate,” “are confident,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “if,” “intend,” “likely,” “may,” “plan,” “potential,” “project,” “should,” “target,” “will,” “would” and other words and terms of similar meaning or that are otherwise tied to future periods or future performance, in each case in all derivative forms. They include statements relating to strategy, goals and expectations concerning our market position, future operations, margins, profitability, capital expenditures, liquidity and capital resources and other financial and operating information. By their nature, forward-looking statements: speak only as of the date they are made; are not statements of historical fact or guarantees of future performance; and are subject to risks, uncertainties, assumptions or changes in circumstances that are difficult to predict or quantify. Our expectations, beliefs and projections are expressed in good faith and we believe there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs and projections will result or be achieved and actual results may vary materially from what is expressed in or indicated by the forward-looking statements.

Many factors determine Company results, and they involve unpredictable risks and uncertainties. Our forward-looking statements depend on our assumptions, our expectations, and our understanding of the economic environment, but they may be inaccurate and may change. We do not guarantee any future performance. Our results could differ materially from those we express or imply in forward-looking statements. The risks, uncertainties and other factors identified in MetLife, Inc.’s filings with the U.S. Securities and Exchange Commission, and others, may cause such differences. These factors include:

(1) economic condition difficulties, including risks relating to interest rates, the effects of announced or future tariff increases on the global economy, credit spreads, declining equity or debt markets, changes in the value of assets under management, real estate, obligors and counterparties, government default or shutdown, currency exchange rates, derivatives, climate change, public health, terrorism and security;

(2) global capital and credit market adversity;

(3) credit facility inaccessibility;

(4) financial strength or credit ratings downgrades;

(5) unavailability, unaffordability, or inadequate reinsurance, including reinsurance risks that arise from reinsurers’ credit risk, and the potential shortfall or failure of risk mitigants to protect against such risks;

(6) statutory life insurance reserve financing costs or limited market capacity;

(7) legal, regulatory, and supervisory and enforcement policy changes;

(8) changes in tax rates, tax laws or interpretations;

(9) litigation and regulatory investigations;

(10) unsuccessful efforts to meet all sustainability standards or to enhance our sustainability;

(11) MetLife, Inc.’s inability to pay dividends and repurchase common stock;

(12) MetLife, Inc.’s subsidiaries’ inability to pay dividends to MetLife, Inc.;

(13) investment defaults, downgrades, or volatility;

(14) investment sales or lending difficulties;

(15) collateral or derivative-related payments;

(16) investment valuations, allowances, or impairments changes;

(17) claims or other results that differ from our estimates, assumptions, or models;

(18) global political, legal, or operational risks;

(19) business competition;

(20) technological changes;

(21) catastrophes;

(22) climate changes or responses to it;

(23) deficiencies in our closed block;

(24) goodwill or other asset impairment, or deferred income tax asset allowance;

(25) impairment of value of business acquired, value of distribution agreements acquired or value of customer relationships acquired;

(26) product guarantee volatility, costs, and counterparty risks;

(27) risk management failures;

(28) insufficient protection from operational risks;

(29) failure to protect confidentiality, integrity or availability of systems or data or other cybersecurity or disaster recovery failures;

(30) accounting standards changes;

(31) excessive risk-taking;

(32) marketing and distribution difficulties;

(33) pension and other postretirement benefit assumption changes;

(34) inability to protect our intellectual property or avoid infringement claims;

(35) acquisition, integration, growth, disposition, or reorganization difficulties;

(36) Brighthouse Financial, Inc. separation risks;

(37) MetLife, Inc.’s Board of Directors influence over the outcome of stockholder votes through the voting provisions of the MetLife Policyholder Trust; and

(38) legal- and corporate governance-related effects on business combinations.

MetLife, Inc. does not undertake any obligation to publicly correct or update any forward-looking statement if MetLife, Inc. later becomes aware that such statement is not likely to be achieved. Please consult any further disclosures MetLife, Inc. makes on related subjects in subsequent reports to the U.S. Securities and Exchange Commission.

Table of Contents

Corporate Information

We encourage investors and others to frequently visit our website (www.metlife.com), including our Investor Relations web pages (https://investor.metlife.com). We announce significant financial and other information to our investors and the public on the Investor Relations web pages, as well as in U.S. Securities and Exchange Commission filings, news releases, public conference calls and webcasts, fact sheets, social media posts, including those of our senior executives, and other documents and media. The information found on our website, including MetLife’s Sustainability Report, is not incorporated by reference into this Quarterly Report on Form 10-Q or in any other report or document we submit to the U.S. Securities and Exchange Commission, and any references to our website are intended to be inactive textual references only.

Table of Contents

Part I — Financial Information

Item 1. Financial Statements

MetLife, Inc.

Interim Condensed Consolidated Balance Sheets

September 30, 2026 and December 31, 2025 (Unaudited)

(In millions, except share and per share data)

September 30, 2026December 31, 2025
Assets
Investments:
Fixed maturity securities available-for-sale, at estimated fair value (net of allowance for credit loss of $185 and $249, respectively); and amortized cost: $351,670 and $337,201, respectively$310,441$315,931
Equity securities, at estimated fair value859858
Contractholder-directed equity securities and fair value option securities, at estimated fair value (includes $2,381 and $1,751, respectively, relating to variable interest entities)15,51613,959
Mortgage loans (net of allowance for credit loss of $1,521 and $1,193, respectively; includes $65 and $35, respectively, of mortgage loans held-for-sale)83,83984,593
Policy loans8,2588,547
Real estate and real estate joint ventures (includes $386 and $378, respectively, under the fair value option; $270 and $132, respectively, of real estate held-for-sale; $425 and $302, respectively, relating to variable interest entities)12,97113,440
Other limited partnership interests15,33714,917
Short-term investments, principally at estimated fair value7,8793,601
Other invested assets (includes $1,559 and $1,698, respectively, of leveraged and direct financing leases; $651 and $560, respectively, relating to variable interest entities)16,72516,332
Total investments471,825472,178
Cash and cash equivalents, principally at estimated fair value (includes $310 and $96, respectively, relating to variable interest entities)19,78622,032
Accrued investment income3,9363,719
Premiums, reinsurance and other receivables (includes $29 and $0, respectively, relating to variable interest entities)51,61549,059
Market risk benefits, at estimated fair value550458
Deferred policy acquisition costs and value of business acquired22,20821,107
Current income tax recoverable (includes $31 and $0, respectively, relating to variable interest entities)213660
Deferred income tax asset4,8372,585
Goodwill9,5449,613
Other assets11,13411,822
Separate account assets148,960151,933
Total assets$744,608$745,166
Liabilities, Mezzanine Equity and Equity
Liabilities
Future policy benefits$199,120$208,855
Policyholder account balances250,333236,857
Market risk benefits, at estimated fair value1,9102,406
Other policy-related balances20,94720,070
Policyholder dividends payable375356
Payables for collateral under securities loaned and other transactions18,50017,115
Short-term debt (includes $109 and $117, respectively, relating to variable interest entities)289355
Long-term debt (includes $57 and $28, respectively, relating to variable interest entities)14,30114,467
Collateral financing arrangement254352
Subordinated debt securities5,1454,155
Notes issued by collateralized financing entities (includes all amounts: under the fair value option; and relating to variable interest entities)1,9401,206
Deferred income tax liability301536
Other liabilities (includes $286 and $167, respectively, relating to variable interest entities)59,51957,582
Separate account liabilities148,960151,933
Total liabilities721,894716,245
Contingencies, Commitments and Guarantees (Note 18)
Mezzanine Equity
Redeemable noncontrolling interests195241
Equity
MetLife, Inc.’s stockholders’ equity:
Preferred stock, par value $0.01 per share; $2,905 aggregate liquidation preference——
Common stock, par value $0.01 per share; 3,000,000,000 shares authorized; 1,196,987,977 and 1,195,587,190 shares issued, respectively; 631,106,615 and 655,333,773 shares outstanding, respectively1212
Additional paid-in capital32,96432,858
Retained earnings47,35244,290
Treasury stock, at cost; 565,881,362 and 540,253,417 shares, respectively(32,798)(30,678)
Accumulated other comprehensive income (loss)(25,304)(18,084)
Total MetLife, Inc.’s stockholders’ equity22,22628,398
Noncontrolling interests293282
Total equity22,51928,680
Total liabilities, mezzanine equity and equity$744,608$745,166

See accompanying notes to the interim condensed consolidated financial statements.

Table of Contents

MetLife, Inc.

Interim Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)

Three Months and Nine Months Ended September 30, 2026 and 2025 (Unaudited)

(In millions, except per share data)

Three Months Ended September 30,Nine Months Ended September 30,
2026202520262025
Revenues
Premiums$11,818$10,555$35,373$33,088
Universal life and investment-type product policy fees1,3851,247

Showing the first 8K of 527K characters. Open the full section

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations

Page
Forward-Looking Statements and Other Financial Information101
Business Overview101
Industry Trends101
Summary of Critical Accounting Estimates103
Acquisitions and Dispositions104
Results of Operations105
Investments123
Derivatives140
Liquidity and Capital Resources141
Adopted Accounting Pronouncements148
Future Adoption of Accounting Pronouncements148
Non-GAAP and Other Financial Disclosures148
Risk Management151

Table of Contents

Forward-Looking Statements and Other Financial Information

For purposes of this discussion, “MetLife,” the “Company,” “we,” “our” and “us” refer to MetLife, Inc., a Delaware corporation incorporated in 1999, its subsidiaries and affiliates. This discussion should be read in conjunction with MetLife, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2025 (the “2025 Annual Report”), the cautionary language regarding forward-looking statements included below, the “Risk Factors” set forth in Part II, Item 1A, and the additional risk factors referred to therein, “Quantitative and Qualitative Disclosures About Market Risk” and the Company’s interim condensed consolidated financial statements included elsewhere herein.

This Management’s Discussion and Analysis of Financial Condition and Results of Operations may contain or incorporate by reference information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. See “Note Regarding Forward-Looking Statements” for cautionary language regarding forward-looking statements.

This Management’s Discussion and Analysis of Financial Condition and Results of Operations includes references to our performance measures, adjusted earnings and adjusted earnings available to common shareholders, that are not based on accounting principles generally accepted in the United States of America (“GAAP”). See “— Non-GAAP and Other Financial Disclosures” for definitions and a discussion of these and other financial measures, and “— Results of Operations” and “— Investments” for reconciliations of historical non-GAAP financial measures to the most directly comparable GAAP measures.

Business Overview

MetLife is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management. In the fourth quarter of 2025, MetLife executed a reorganization to align with its strategic initiative to accelerate growth in asset management. As part of this reorganization, the Company adjusted its segment structure. MetLife Investment Management, the Company’s institutional asset management business (“MIM”), which was previously reported in Corporate & Other, became a reportable segment. MetLife Holdings was removed as a reportable segment, and its business is now primarily reported in Corporate & Other. Additionally, certain products formerly reported in MetLife Holdings were moved to Group Benefits and Retirement and Income Solutions (“RIS”). These changes were applied retrospectively for all periods presented, did not have an impact on prior period consolidated net income (loss) or consolidated adjusted earnings, and are collectively referred to as the “Strategic Reorganization.” As a result of the Strategic Reorganization, MetLife is organized into the following six segments: Group Benefits; RIS; Asia; Latin America; Europe, the Middle East and Africa (“EMEA”); and MIM. In addition, the Company continues to report certain of its results of operations in Corporate & Other. See “Business — Segments and Corporate & Other” included in the 2025 Annual Report and Notes 1 and 2 of the Notes to the Interim Condensed Consolidated Financial Statements for further information on the Company’s segments and Corporate & Other and the Strategic Reorganization.

Industry Trends

We continue to be impacted by the changing global financial and economic environment that has been affecting the industry.

Financial and Economic Environment

Our business and results of operations are materially affected by conditions in the global financial markets and the economy generally due to our market presence in numerous countries, our large investment portfolio and the sensitivity of our insurance liabilities and derivatives to changing market factors.

Table of Contents

Governments and central banks around the world use fiscal and monetary policies to address uncertain economic conditions. In the United States (“U.S.”), the Federal Open Market Committee (“FOMC”) took various actions in 2025 to promote employment and combat inflation, including lowering interest rates in the second half of the year and ending the process of quantitative tightening. While rates remained steady for most of 2026, the FOMC raised interest rates in September 2026. Labor market conditions, inflation, and financial and international developments, as well as other factors, could result in further policy adjustments. Other central banks have recently diverged on monetary policies, with some raising rates while others have held rates steady, reflecting differing local economic conditions and views on the impact of the foregoing factors. We are closely monitoring these and other political and economic conditions that might contribute to global market volatility and impact our business operations, investment portfolio, value of our assets under management (“AUM”), and derivatives, such as global inflation, supply chain disruptions, acts of war, banking sector volatility and employment and work policies of the U.S. federal government. We are also monitoring the imposition of tariffs, sanctions or other barriers to international trade, changes to international trade agreements, and their potential impacts on our business, results of operations and financial condition. See “— Investments — Current Environment,” as well as “Management’s Discussion and Analysis of Financial Condition and Results of Operations — Industry Trends — Impact of Market Interest Rates — Effects of Inflation” in the 2025 Annual Report.

Impact of Market Interest Rates

Market interest rates are a key driver of our results. Increases and decreases in such rates, as well as extended periods of stagnation, may impact our business and investments in various ways. In o

Showing the first 8K of 242K characters. Open the full section

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We regularly analyze our exposure to interest rate, equity market price and foreign currency exchange rate risks. As a result of that analysis, we have determined that the estimated fair values of certain assets and liabilities are materially exposed to changes in interest rates, foreign currency exchange rates and changes in the equity markets. We have exposure to such market risks through our insurance operations and investment activities. We use a variety of strategies to manage these risks, including the use of derivatives. A description of our market risk exposures may be found under “Quantitative and Qualitative Disclosures About Market Risk” included in the 2025 Annual Report. There have been no material changes to our market risk exposures from those previously disclosed in the 2025 Annual Report.

Table of Contents

Item 4. Controls and Procedures

Management, with the participation of the CEO and CFO, has evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (“Exchange Act”), as of the end of the period covered by this report. Based on that evaluation, the CEO and CFO have concluded that these disclosure controls and procedures are effective.

There were no material changes to the Company’s internal control over financial reporting as defined in Exchange Act Rule 13a-15(f) during the quarter ended September 30, 2026 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

Table of Contents

Part II — Other Information

Item 1. Legal Proceedings

See Note 18 of the Notes to the Interim Condensed Consolidated Financial Statements.

Item 1A. Risk Factors

Certain factors that may affect the Company’s business or operations are described under “Risk Factors” in Part I, Item 1A, of the 2025 Annual Report. There have been no material changes to our risk factors from the risk factors previously disclosed in the 2025 Annual Report.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities

Purchases of MetLife, Inc. common stock made by or on behalf of MetLife, Inc. or its affiliates during the quarter ended September 30, 2026 are set forth below:

PeriodTotal Number of Shares Purchased (1)Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or ProgramsMaximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs (2)
July 1 - July 31, 20262,331,398$92.562,331,398$406,685,935
August 1 - August 31, 20262,909,369$96.412,909,369$3,126,186,544
September 1 - September 30, 20261,596,844$96.441,596,844$2,972,186,004
Total6,837,6116,837,611

(1)During the periods presented, separate account index funds did not purchase any MetLife, Inc. common stock on the open market in non-discretionary transactions.

(2)In August 2026, MetLife, Inc. announced that its Board of Directors authorized an additional $3.0 billion of common stock repurchases. At September 30, 2026, MetLife, Inc. had $3.0 billion of common stock repurchases remaining under its authorization. Neither the authorization remaining, nor the amount repurchased, reflect the applicable excise tax payable in connection with such repurchases. For more information on our common stock authorizations and common stock repurchases, including the excise tax payable in connection therewith, see Note 13 of the Notes to the Interim Condensed Consolidated Financial Statements. See also “Risk Factors — Capital Risks — We May Not be Able to Pay Dividends or Repurchase Our Stock Due to Legal and Regulatory Restrictions or Cash Buffer Needs” included in the 2025 Annual Report.

Table of Contents

Item 5. Other Information

Securities trading plans

During the three months ended September 30, 2026, none of our Section 16 officers or directors (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or any “non-Rule 10b5-1 trading arrangement” (as defined in Item 408(c) of Regulation S-K).

Table of Contents

Item 6. Exhibits

Incorporated by Reference
Exhibit No.DescriptionFormFile NumberExhibitFiling DateFiled or Furnished Herewith
31.1Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X
31.2Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.X
32.1Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.X
32.2Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.X
101.SCHInline XBRL Taxonomy Extension Schema Document.X
101.CALInline XBRL Taxonomy Extension Calculation Linkbase Document.X
101.DEFInline XBRL Taxonomy Extension Definition Linkbase Document.X
101.LABInline XBRL Taxonomy Extension Label Linkbase Document.X
101.PREInline XBRL Taxonomy Extension Presentation Linkbase Document.X
101.INSXBRL Instance Document - the instance document does not appear in the Interactive Data file because its XBRL tags are embedded within the Inline XBRL document.X
104Cover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101).X

Table of Contents

Glossary

Throughout this Form 10-Q, the Company may use certain abbreviations, acronyms and terms which are further detailed below.

A.M. BestA.M. Best Company, Inc.Company Action Level RBCMinimum level of TAC before corrective action commences is twice authorized control level RBC
ABOAccumulated Benefit ObligationsCredit FacilityUnsecured revolving credit facility
ABS & CLOAsset-Backed Securities and Collateralized Loan ObligationsCROChief Risk Officer
ACLAllowance For Credit LossC-ROSSChina Risk Oriented Solvency System
AD&DAccidental Death and DismembermentCSRDCorporate Sustainability Reporting Directive
AFSAvailable-For-SaleCybersecurity Model LawNAIC’s Insurance Data Security Model Law
AIArtificial IntelligenceDACDeferred Policy Acquisition Costs
ALMAsset/Liability ManagementDeferred SharesAwards that have become payable in shares but the issuance of which has been deferred
Alt-AAlternative Residential Mortgage LoansDelaware CommissionerDelaware Commissioner of Insurance
American LifeAmerican Life Insurance CompanyDodd-FrankDodd-Frank Wall Street Reform and Consumer Protection Act
AOCIAccumulated Other Comprehensive Income (Loss)DOLU.S. Department of Labor
APBOAccumulated Postretirement Benefit ObligationDPLDeferred Profit Liability
ASOAdministrative Services-OnlyDSCRDebt Service Coverage Ratios
ASUAccounting Standards UpdateEEAEuropean Economic Area
AUMAssets Under ManagementEMEAEurope, the Middle East and Africa
Authorized Control Level RBCAuthorized Control Level RBC, calculated in the manner prescribed by the NAICERCEnterprise Risk Committee
BrighthouseBrighthouse Financial, Inc. and its SubsidiariesERISAEmployee Retirement Income Security Act of 1974
CBIRCThe China Banking and Insurance Regulatory CommissionERMEnterprise Risk Management
CCPACalifornia Consumer Privacy ActEUEuropean Union
CEOChief Executive OfficerEU AI ActEuropean Union’s Artificial Intelligence Act
CFEsCollateralized Financing EntitiesExchange ActSecurities Exchange Act of 1934, as amended
CFOChief Financial OfficerFarmer MacFederal Agricultural Mortgage Corporation
CFPBConsumer Financial Protection BureauFASBFinancial Accounting Standards Board
CFTCCommodity Futures Trading CommissionFDICFederal Deposit Insurance Corporation
ChariotChariot Holding Company, LPFederal ReserveFederal Reserve Board & Federal Reserve Bank of New York
Chariot ReChariot Reinsurance, Ltd.Federal Reserve BoardBoard of Governors of the Federal Reserve System
CISOChief Information Security OfficerFHLBNYFederal Home Loan Bank of New York
CLO InvestmentsCLO Fund InvestmentsFINRAFinancial Industry Regulatory Authority
CLOsCollateralized Loan ObligationsFIOFederal Insurance Office
CMBSCommercial Mortgage-Backed SecuritiesFitchFitch Ratings Inc.
COLICompany-Owned Life Insurance PoliciesFPBsFuture Policy Benefits
Committed FacilitiesCredit Facility, as well as certain committed facilitiesFSAFinancial Services Agency in Japan

Table of Contents

FSBFinancial Stability BoardMrHMetLife Reinsurance Company of Hamilton, Ltd.
FSOCFinancial Stability Oversight CouncilMRVMetLife Reinsurance Company of Vermont
FVOFair Value OptionMSSMetLife Services and Solutions, LLC
GAAPAccounting principles generally accepted in the United States of AmericaMTLMetropolitan Tower Life Insurance Company
GCCGroup Capital CalculationNAICNational Association of Insurance Commissioners
GDPRGeneral Data Protection RegulationNAVNet Asset Value
GICsGuaranteed Interest ContractsNebraska DirectorDirector of the Nebraska Department of Insurance
GILTIGlobal Intangible Low-Taxed IncomeNGEsNon-Guaranteed Elements
GMABsGuaranteed Minimum Accumulation BenefitsNIFONet investment in a foreign operation
GMCRGuaranteed Minimum Crediting RatesNon-Bank SIFINon-Bank Systemically Important Financial Institution
GMDBsGuaranteed Minimum Death BenefitsNPRNet Premium Ratio
GMIBsGuaranteed Minimum Income BenefitsNQMNonqualified Residential Mortgage
GMWBsGuaranteed Minimum Withdrawal BenefitsNRSRONationally Recognized Statistical Rating Organizations
GMXBsGuaranteed Minimum BenefitsNYDFSNew York State Department of Financial Services
IAIGsInternationally Active Insurance GroupsOCIOther Comprehensive Income (Loss)
IAISInternational Association of Insurance SupervisorsOLPIOther Limited Partnership Interests
IBNPIncurred But Not PaidOTCOver-the-Counter
IBNRIncurred But Not ReportedOTC-bilateralBilateral contracts between two counterparties
IMRInterest Maintenance ReserveOTC-clearedOTC derivatives are cleared and settled through central clearing counterparties
Invested PlansAssets of the qualified pension plans and postretirement medical plansPABsPolicyholder Account Balances
IRSInternal Revenue ServicePBOProjected Benefit Obligation
LDTILong-Duration Targeted ImprovementsPCAOBPublic Company Accounting Oversight Board
LDTI Transition DateJanuary 1, 2021Phantom Stock-Based AwardsCash-settled awards based in whole or in part on the price of shares or changes in the price of shares
LIBORLondon Interbank Offered RatePineBridgePineBridge Investments
LTVLoan-To-ValuePTEProhibited Transaction Exemption
MetLife MalaysiaAmMetLife Insurance Berhad (Malaysia) and AmMetLife Takaful Berhad (Malaysia)RBCRisk-Based Capital
MetLife UkrainePJSC MetLifeRCCReplacement Capital Covenant
MIMMetLife Investment Management, the Company’s institutional asset management businessREJVsReal Estate Joint Ventures
MLICMetropolitan Life Insurance CompanyRetiree VEBAU.S. Retiree Health and Welfare Benefit Obligations
Moody’sMoody’s Investors Service, Inc.RISRetirement and Income Solutions
MoReMissouri Reinsurance, Inc.RMBSResidential Mortgage-Backed Securities
MrBMetLife Reinsurance Company of Bermuda, Ltd.ROURight-of-Use
MRBMarket Risk BenefitSCLSpecial Considerations Letter
MRCMetLife Reinsurance Company of CharlestonSECU.S. Securities and Exchange Commission

Table of Contents

SeparationDistribution of shares of Brighthouse Financial, Inc. common stock to the MetLife, Inc. common shareholdersTACTotal Adjusted Capital, calculated in the manner prescribed by the NAIC
Series A preferred stockNon-Cumulative Preferred Stock, Series ATRRsTotal Rate of Return Swaps
Series D preferred stock5.875% Fixed-To-Floating Rate Non-Cumulative Preferred Stock, Series DU.K.United Kingdom
Series E preferred stock5.625% Non-Cumulative Preferred Stock, Series EU.S.United States
Series F preferred stock4.75% Non-Cumulative Preferred Stock, Series FULSGUniversal and Variable Universal Life Policies with Secondary Guarantees
Series G preferred stock3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series GUnit-linked and FVO SecuritiesContractholder-directed equity securities and FVO securities
SOFRSecured Overnight Financing RateUnit-linked investmentsContractholder-directed investments supporting unit-linked variable annuity type liabilities
SSGStructured Securities GroupUREVUnearned Revenue
Statement-Based Combined RBC RatioInternally defined Combined RBC RatioVIEsVariable Interest Entities
Statutory CodificationCodification of Statutory Accounting PrinciplesVMValuation Manual
Structured ProductsRMBS, ABS & CLO and CMBSVOBAValue of Business Acquired
SuperintendentNew York Superintendent of Financial ServicesVOCRAValue of Customer Relationships Acquired
S&PStandard & Poor’s Global RatingsVODAValue of Distribution Agreements

Table of Contents

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

METLIFE, INC.
By:/s/ Adrienne O’Neill
Name: Adrienne O’Neill Title: Executive Vice President and Chief Accounting Officer (Authorized Signatory and Principal Accounting Officer)

Date: November 5, 2026